Sodium Chlorite Compositions with Enhanced Anti-Viral and Anti-Microbial Efficacy and Reduced Toxicity
AssigneeiRenix Medical, Inc.
InventorsStephen J. Smith, Thomas W. Chalberg, JR.
Life of this patent
Estimating the term…
Abstract
Methods of treating a subject for a microbial eye condition are provided. Aspects of the methods include administering to the subject an activated sodium chlorite composition, where the compositions include sodium chlorite; and a buffer component prepared from sodium phosphate monobasic monohydrate and citric acid. Also provided are methods of inhibiting a virus associated with a tissue, such as an adenovirus or coronavirus. In addition, delivery devices for administering an activated sodium chlorite composition to a tissue are provided.
Claims21
1-71. (canceled)
A delivery device comprising:
- (a) a first container comprising a sodium chlorite stock solution;
- and
- (b) a second container comprising an activating buffer;
- wherein the device is configured to combine the sodium chlorite stock solution and activating buffer to produce an activated sodium chlorite composition and administer the activated sodium chlorite composition to a subject.
A method comprising:
- (a) providing
- (i) a first container comprising a sodium chlorite stock solution;
- and
- (ii) a second container comprising an activating buffer;
- and
- (b) combining the sodium chlorite stock solution and activating buffer to produce an activated sodium chlorite composition.
A kit comprising:
- (a) a first container comprising a sodium chlorite stock solution;
- and
- (b) a second container comprising an activating buffer;
- wherein the first and second containers are configured to combine the sodium chlorite stock solution and activating buffer to produce an activated sodium chlorite composition.
Dependencies are inferred from the claim text.